[{"ID":"6768_15-2021_NCT01911351","TOPIC_YEAR":2021,"RESPONSE":"$}}%C%>\n\nB: excluded\n\nThe patient is not eligible for the clinical trial because the trial is focused on pediatric patients undergoing minor procedures, and the patient is an adult (70 years old). Additionally, the patient has a history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia, which are not behavioral disorders but are physical health conditions that are not relevant to the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9881327933},{"ID":"35712_75-2021_NCT03888287","TOPIC_YEAR":2021,"RESPONSE":"$}}%C%]\n\nBased on the information provided, the patient is not eligible for the clinical trial because the trial is only for patients with Parkinson's disease who are in the adult inpatient units of Hackensack University Medical Center, and the patient is not currently an inpatient. Additionally, the patient is not under the age of 21, and does not meet any of the exclusion criteria. Therefore, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9902398076},{"ID":"5479_12-2021_NCT03686527","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded.\n\nThe patient is not eligible for the clinical trial because she does not have aortic valve stenosis, which is the condition being studied in the clinical trial. The patient has mitral valve prolapse and regurgitation, which is a different condition. Additionally, the patient has a history of Marfan's syndrome, which is not listed as an inclusion criterion in the clinical trial.","PROBA":0.9855492946},{"ID":"7035_15-2021_NCT04254692","TOPIC_YEAR":2021,"RESPONSE":"#C: Irrelevant\n\nThe patient is not eligible for the clinical trial because the trial is focused on abdominoplasty, which is a surgical procedure to improve the appearance of the abdomen, and the patient does not have this condition. The patient has a history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia, but these conditions are not related to the topic of the clinical trial.","PROBA":0.9972584892},{"ID":"35514_75-2021_NCT02098642","TOPIC_YEAR":2021,"RESPONSE":"#C: irrelevant","PROBA":0.6567513645},{"ID":"5288_12-2021_NCT01242397","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.8552615419},{"ID":"30755_65-2021_NCT02411578","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.9886137918},{"ID":"35435_75-2021_NCT01399905","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.9838229194},{"ID":"35648_75-2021_NCT03409120","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20C%3A%20irrelevant%20\n\nThe patient is not eligible for the clinical trial because they do not have dystonia associated with Parkinson's disease. The clinical trial is specifically focused on dystonia, and the patient's symptoms are more consistent with mild Parkinson's disease without dystonia. Therefore, the patient is \"irrelevant\" for the clinical trial.","PROBA":0.9784234609},{"ID":"17169_36-2021_NCT02610660","TOPIC_YEAR":2021,"RESPONSE":"$}}%C%] C: irrelevant. The patient is not eligible for the clinical trial because the patient does not have pulmonary hypertension, which is the focus of the clinical trial. The patient's weight concerns and obesity are not related to pulmonary hypertension.","PROBA":0.9865579926},{"ID":"6703_15-2021_NCT01360918","TOPIC_YEAR":2021,"RESPONSE":"#C: irrelevant\n\nThe patient is not eligible for the clinical trial because she does not have atrial fibrillation, which is the primary inclusion criterion for the study. Additionally, she is over the age limit of 70 years, which is an exclusion criterion.","PROBA":0.9949673909},{"ID":"30417_65-2021_NCT00211510","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20eligible%20C%3A%20irrelevant%20B:%20excluded%E2%80%8B","PROBA":0.983864381},{"ID":"5466_12-2021_NCT03549052","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.9404241741},{"ID":"30870_65-2021_NCT03605979","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is eligible for the clinical trial. The patient has type 1 diabetes, which is the same condition being studied in the clinical trial. The patient is also within the age range specified in the inclusion criteria (18-100 years) and does not have any of the exclusion criteria listed (such as pregnancy, serious diseases that could interfere with the study, etc.). Therefore, the patient is eligible for the clinical trial.","PROBA":0.9788836078},{"ID":"7000_15-2021_NCT03955081","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is not eligible for the clinical trial because the trial is focused on deep enteroscopy for diagnosis and treatment of gastrointestinal diseases, and the patient's condition is not related to that. The patient has been diagnosed with pancreatic adenocarcinoma, which is not a gastrointestinal disease. Therefore, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9921564395},{"ID":"6882_15-2021_NCT02882503","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is not eligible for the clinical trial because she has a history of CAD and is not willing to undergo surgery, which are both exclusion criteria for the study. Additionally, the patient has a history of hyperlipemia, hypertension, and chronic kidney disease, which could make surgery more risky and are also exclusion criteria for the study.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9696134833},{"ID":"6848_15-2021_NCT02580422","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible\n\nThe patient is eligible for the clinical trial because they have a diagnosis of pancreatic cancer and are experiencing weight loss, which are both criteria for inclusion in the study. Additionally, the patient does not have any of the exclusion criteria, such as known history of congestive heart failure or pulmonary disease, that would preclude them from participating in the study.","PROBA":0.9925661814},{"ID":"6620_15-2021_NCT00580749","TOPIC_YEAR":2021,"RESPONSE":"","PROBA":0.5068582506},{"ID":"5436_12-2021_NCT03155373","TOPIC_YEAR":2021,"RESPONSE":"$}}%C%]\n\nBased on the information provided, the patient is not eligible for the clinical trial because she has secondary mitral regurgitation, which is an exclusion criterion. Additionally, the patient has a known history of Marfan's syndrome and severe mitral valve prolapse, which are not included in the inclusion criteria.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9783830815},{"ID":"6633_15-2021_NCT00663247","TOPIC_YEAR":2021,"RESPONSE":"#A: eligible","PROBA":0.9985610694}]
